The latest announcement is out from Invivyd ( (IVVD) ).

A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important ...

As we prepare for the festive season, it’s easy to let COVID boosters fall off our to-do lists. But COVID is still ...

Jonathan Strober, MD, discusses promising results from the VIBRANCE-MG trial, highlighting nipocalimab's safety and efficacy for pediatric myasthenia gravis.

Sally and Steve Holt were clinically extremely vulnerable during the pandemic. But six years later they are still shielding, ...

A memo from Dr. Vinay Prasad​, the head of the FDA's Center for Biologics Evaluation and Research, may signal an effort to to ...

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, ...

The concept of vaccination was first developed in the 19th century when Dr. Edward Jenner made the observation that milkmaids ...

Myocarditis has become a flashpoint in debates about COVID vaccines; however, new research suggests this rare heart ...

FDA officials want to rewrite the rules governing vaccines, but former leaders warn the changes could have lasting ...

After patient deaths from interstitial lung disease in a lung cancer trial testing the antibody-drug conjugate ifinatamab deruxtecan, the FDA placed a partial hold on Daiichi Sankyo and Merck's global ...